What Are Research Peptides?
How peptides function as signaling molecules and why they're studied in laboratory research.
Read Article →Neutral, science-first overviews to support informed research decisions. Purely educational — no medical advice, dosing, or human-use guidance.
Peptides are short chains of amino acids that occur naturally in living organisms, where they play a central role in biological signaling, cellular communication, and structural processes. In laboratory settings they are studied to better understand metabolism, tissue structure, hormone signaling, and cellular regulation.
Because peptides are fundamental to many biological systems, researchers use them in controlled environments to investigate how cells communicate, adapt, and maintain function. The articles below expand on these topics—organized so you can find what's relevant to your research quickly.
Explore the Library →New overviews are added regularly. Each article is written for research context only.
How peptides function as signaling molecules and why they're studied in laboratory research.
Read Article →Background on this pentadecapeptide and the tissue-repair pathways researchers investigate.
Read Article →An introduction to compounds studied for energy regulation and metabolic signaling.
Read Article →Explore our complete peptide research guide covering types of peptides, how they work, current scientific research, potential applications, safety, and more.
Read Article →Learn more about Selank and its nootropic effects.
Read Article →The copper-binding peptide's role in collagen synthesis, wound healing, and tissue remodeling research.
Read Article →The mitochondrial-derived peptide studied for AMPK activation, glucose metabolism, and exercise adaptation.
Read Article →The dual GIP/GLP-1 receptor agonist's mechanism, SURPASS trial findings, and regulatory status.
Read Article →The ACTH-derived neuropeptide studied for BDNF/NGF signaling and stroke-recovery research.
Read Article →The MC1R-selective melanocortin peptide's Phase 3 findings and how it differs from Melanotan II.
Read Article →Triple GIP/GLP-1/glucagon receptor mechanism and full TRIUMPH Phase 3 trial findings, with direct citations.
Read Article →A deep dive on each component of Glow — BPC-157, TB-500, and GHK-Cu — with direct research citations.
Read Article →GHRH mechanism, pivotal NEJM/JAMA trials, a 2026 meta-analysis, and its FDA-approved indication.
Read Article →The cellular coenzyme's role in aging research, the NADPARK/NR-SAFE trials, and the evidence gap between commercial NAD+ and controlled research.
Read Article →Semaglutide, tirzepatide, and retatrutide compared — mechanisms, trial data, and regulatory status.
Read Article →The 0.9% benzyl alcohol difference, FDA labeling, and which diluent to choose for reconstitution.
Read Article →The legal origin of RUO in FDA diagnostic regulation, and how it applies to research chemicals.
Read Article →The exact composition of both blends, and the research behind KPV — Klow's key addition.
Read Article →Diluent selection, laboratory mixing technique, and stock-solution concentration chemistry.
Read Article →Degradation pathways, freeze-thaw risks, and stability timeframes from the research literature.
Read Article →A line-by-line guide to HPLC purity figures, mass spec identity confirmation, batch numbers, and COA red flags.
Read Article →How the two analytical methods behind every credible COA actually work — purity by HPLC, identity by mass spec.
Read Article →Comparing two structurally unrelated tissue-repair peptides — origin, mechanisms, and what the literature shows.
Read Article →Longer, citation-heavy articles on mechanisms, trial comparisons, evidence quality and laboratory practice.
Why a third receptor was added to the GIP/GLP-1 backbone, and what preclinical and trial data report.
Read Article →Receptor pharmacology plus the SURPASS-2 and SURMOUNT-5 head-to-head trial data.
Read Article →What the Connectivity Map analyses report about GHK-Cu, and the limits of in silico evidence.
Read Article →Humanin, MOTS-c and SHLPs: how mitochondrial DNA encodes signaling peptides.
Read Article →Tesamorelin, sermorelin and CJC-1295: structure, half-life, and evidence base.
Read Article →A 2025 systematic review found 35 preclinical studies and one small clinical study. What that means.
Read Article →Two Russian-developed neuropeptides compared: origins, gene-expression data, and evidence gaps.
Read Article →NR, NMN and NAD+ itself: biosynthesis, human trials, and measurement pitfalls.
Read Article →Preservative chemistry, USP efficacy testing, assay interference, and documented limits.
Read Article →What lab accreditation does and does not certify, plus a COA verification checklist.
Read Article →